Email
Facebook
LinkedIn
Twitter
Digg
Google
The new Clinical and Translational Research Center, a 170,000 square-foot research facility that houses the laboratories of several UB physician-scientists.
The University at Buffalo has made another major addition to its campus: the Clinical and Translational Research Center (CTRC).
The School of Medicine and Biomedical Sciences held the grand opening of its CTRC in the joint UB-Kaleida Health building at Goodrich and Ellicott streets in downtown Buffalo on September 20.
The 170,000-square-foot research facility allows UB’s physician-scientists to see patients, conduct research and work with clinicians downstairs in Kaleida Health’s Gates Vascular Institute. The CTRC’s offices and laboratories occupy the building’s top four floors, while Gates Vascular Institute is housed on the bottom four.
The CTRC is an important step in the relocation of UB’s medical school to downtown Buffalo. When it is completed by 2016, the new medical school will bring approximately 1,200 people to downtown Buffalo. In total, the CTRC and medical school projects will create more than 3,000 jobs, 250 of which are physician-scientists and staff.
The new facility houses the laboratories of some of UB’s highest-profile researchers, who collectively have earned more than $25 million in research funding. They are conducting research to develop treatments for a broad range of diseases and conditions, including diabetes and obesity, cardiovascular disease, HIV/AIDS and Alzheimer’s and memory disorders.
In addition to custom-designed laboratories and common spaces, the CTRC includes:
- Clinical Research Center, which coordinates clinical research activities among institutions in the Buffalo Translational Consortium.
- Center for Research in Cardiovascular Medicine, an interdisciplinary research center.
- Jacobs Institute, which conducts research, development and training in vascular medicine.
- Toshiba Stroke and Vascular Research Center
- Biosciences Incubator, to assist UB researchers with the commercialization of new medical therapies.
For more information on the new CTRC, read the UB Reporter article.
